Changes in co-receptor-use by human immunodeficiency virus type 1 (HIV-1) strains are relatively rare in vivo. Here we describe two variants derived from the CCR5-using strain SF162, selected for replication in the C8166 T-cell line. Amino acid substitutions in the V3 loop conferred CXCR4-use; however, the loss of macrophage-tropism by one variant was due to a single mutation in the start codon of vpu. We discuss how V3 loop and vpu mutations acquired by replication in T-cell lines in vitro correlate with similar changes reported for primary isolates and HIV-1 sequences in vivo.
AgaceW. W.,
AmaraA.,
RobertsA. I.,
PablosJ. L.,
ThelenM.,
UguccioniM.,
LiX. Y.,
MarsalJ.,
Arenzana-SeisdedosF.,
DelauneyT.,
EbertE. C.,
MoserB.,
ParkerC. M.2000; Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Current Biology 10:325–328
AsjoB.,
Morfeldt MansonL.,
AlbertJ.,
BiberfeldG.,
KarlssonA.,
LidmanK.,
FenyoE. M.1986; Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii:660–662
BallietJ. W.,
KolsonD. L.,
EigerG.,
KimF. M.,
McGannK. A.,
SrinivasanA.,
CollmanR.1994; Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology 200:623–631
ConnorR. I.,
HoD. D.1994; Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. Journal of Virology 68:4400–4408
ConnorR. I.,
SheridanK. E.,
CeradiniD.,
ChoeS.,
LandauN. R.1997; Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. Journal of Experimental Medicine 185:621–628
De JongJ. J.,
De RondeA.,
KeulenW.,
TersmetteM.,
GoudsmitJ.1992; Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. Journal of Virology 66:6777–6780
DejucqN.,
SimmonsG.,
ClaphamP. R.1999; Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4+ T-cell lines determined by the capacity to exploit low concentrations of CCR5. Journal of Virology 73:7842–7847
Di MarzioP.,
TseJ.,
LandauN. R.1998; Chemokine receptor regulation and HIV type 1 tropism in monocyte macrophages. AIDS Research and Human Retroviruses 14:129–138
FouchierR. A.,
GroeninkM.,
KootstraN. A.,
TersmetteM.,
HuismanH. G.,
MiedemaF.,
SchuitemakerH.1992; Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. Journal of Virology 66:3183–3187
HarroweG.,
Cheng-MayerC.1995; Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 210:490–494
Holm-HansenC.,
GrothuesD.,
RustadS.,
RosokB.,
PascuF. R.,
AsjoB.1995; Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. AIDS Research and Human Retroviruses 11:597–603
KawamuraM.,
IshizakiT.,
IshimotoA.,
ShiodaT.,
KitamuraT.,
AdachiA.1994; Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. Journal of General Virology 75:2427–2431
KlasseP. J.,
BoydM. T.,
WeissR. A.,
SchulzT. F.1996; Mutations in the vpu, env, and nef genes of a syncytium-inducing variant of HIV type 1 JR-CSF that infects a range of T cell lines. AIDS Research and Human Retroviruses 12:347–350
LamaJ.,
MangasarianA.,
TronoD.1999; Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Current Biology 9:622–631
LatheyJ. L.,
PrattR. D.,
SpectorS. A.1997; Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1. Journal of Infectious Diseases 175:231–232
PablosJ. L.,
AmaraA.,
BoulocA.,
SantiagoB.,
CaruzA.,
GalindoM.,
DelaunayT.,
VirelizierJ. L.,
Arenzana-SeisdedosF.1999; Stromal cell derived factor is expressed by dendritic cells and endothelium in human skin. American Journal of Pathology 155:1577–1586
ScarlattiG.,
TresoldiE.,
BjorndalA.,
FredrikssonR.,
ColognesiC.,
DengH. K.,
MalnatiM. S.,
PlebaniA.,
SiccardiA. G.,
LittmanD. R.,
FenyoE. M.,
LussoP.1997; In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nature Medicine 3:1259–1265
SchubertU.,
ClouseK. A.,
StrebelK.1995; Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. Journal of Virology 69:7699–7711
SchubertU.,
Ferrer-MontielA. V.,
Oblatt-MontalM.,
HenkleinP.,
StrebelK.,
MontalM.1996; Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Letters 398:12–18
SchubertU.,
AntonL. C.,
BacikI.,
CoxJ. H.,
BourS.,
BenninkJ. R.,
OrlowskiM.,
StrebelK.,
YewdellJ. W.1998; CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. Journal of Virology 72:2280–2288
SchubertU.,
BourS.,
WilleyR. L.,
StrebelK.1999; Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env. Journal of Virology 73:887–896
ShiodaT.,
LevyJ. A.,
Cheng-MayerC.1991; Macrophage and T cell line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349:167–169
SimmonsG.,
McKnightA.,
TakeuchiY.,
HoshinoH.,
ClaphamP. R.1995; Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: a V3 loop-determined restriction. Virology 209:696–700
SimmonsG.,
WilkinsonD.,
ReevesJ. D.,
DittmarM. T.,
BeddowsS.,
WeberJ.,
CarnegieG.,
DesselbergerU.,
GrayP. W.,
WeissR. A.,
ClaphamP. R.1996; Primary syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. Journal of Virology 70:8355–8360
SimmonsG.,
ReevesJ. D.,
McKnightA.,
DejucqN.,
HibbittsS.,
PowerC. A.,
AaronsE.,
ScholsD.,
ClercqE. D.,
ProudfootA. E. I.,
ClaphamP. R.1998; CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. Journal of Virology 72:8453–8457
TersmetteM.,
de GoedeR. E.,
AlB. J.,
WinkelI. N.,
GrutersR. A.,
CuypersH. T.,
HuismanH. G.,
MiedemaF.1988; Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Journal of Virology 62:2026–2032
VeraniA.,
PesentiE.,
PoloS.,
TresoldiE.,
ScarlattiG.,
LussoP.,
SiccardiA. G.,
VercelliD.1998; CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. Journal of Immunology 161:2084–2088
YiY.,
RanaS.,
TurnerJ. D.,
GaddisN.,
CollmanR. G.1998; CXCR4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. Journal of Virology 72:772–777